These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3348170)

  • 1. Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects.
    Nakhleh R; Vogt JM; Edson JR
    Am J Clin Pathol; 1988 Mar; 89(3):353-8. PubMed ID: 3348170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of purified dermatan sulfate for heparin cofactor II (HC II) assay.
    Ruzzenente O; Ghidini R; Poli G; Schiavon R; Guidi GC
    Thromb Res; 1992 Jan; 65(2):281-7. PubMed ID: 1579900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
    Dupouy D; Sié P; Dol F; Boneu B
    Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II: a simple assay method and results of its clinical application.
    Vinazzer H; Pangraz U
    Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB; Newton GR; Doctor VM
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin cofactor II: experimental approach to a new assay and clinical results.
    Vinazzer H; Stocker K
    Thromb Res; 1991 Feb; 61(3):235-41. PubMed ID: 2028443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
    Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of thrombin and chymotrypsin by heparin-cofactor II.
    Struss D; Storck J; Zimmermann RE
    Thromb Res; 1992 Oct; 68(1):45-56. PubMed ID: 1333106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
    Hurst RE; Poon MC; Griffith MJ
    J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II.
    Sié P; Petitou M; Lormeau JC; Dupouy D; Boneu B; Choay J
    Biochim Biophys Acta; 1988 Aug; 966(2):188-95. PubMed ID: 3401503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.